<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000045208"><TermName>decitabine</TermName><TermPronunciation>(deh-SIH-tuh-been)</TermPronunciation><TermDefinition><DefinitionText>A drug that is used to treat myelodysplastic syndromes and is being studied in the treatment of other types of cancer. It is a type of antimetabolite. Also called Dacogen.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000705154" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;decitabine&quot;" language="en" id="_3"/><MediaLink ref="CDR0000705155" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;decitabina&quot;" language="es" id="_4"/><SpanishTermName>decitabina</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para tratar los síndromes mielodisplásicos y que se estudia para tratar otros tipos de cáncer. Es un tipo de antimetabolito. También se llama Dacogen.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2007-07-06</DateLastModified><RelatedInformation><RelatedDrugSummaryRef href="CDR0000495366">Decitabine</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
